3-184104260-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001256613.2(HTR3E):āc.358C>Gā(p.Leu120Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000444 in 1,613,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001256613.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTR3E | NM_001256613.2 | c.358C>G | p.Leu120Val | missense_variant | 4/9 | ENST00000415389.6 | NP_001243542.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTR3E | ENST00000415389.6 | c.358C>G | p.Leu120Val | missense_variant | 4/9 | 1 | NM_001256613.2 | ENSP00000401444.2 |
Frequencies
GnomAD3 genomes AF: 0.000257 AC: 39AN: 152044Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000272 AC: 68AN: 250186Hom.: 0 AF XY: 0.000237 AC XY: 32AN XY: 135242
GnomAD4 exome AF: 0.000464 AC: 678AN: 1460914Hom.: 0 Cov.: 31 AF XY: 0.000462 AC XY: 336AN XY: 726744
GnomAD4 genome AF: 0.000256 AC: 39AN: 152162Hom.: 0 Cov.: 30 AF XY: 0.000175 AC XY: 13AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2024 | The c.403C>G (p.L135V) alteration is located in exon 3 (coding exon 3) of the HTR3E gene. This alteration results from a C to G substitution at nucleotide position 403, causing the leucine (L) at amino acid position 135 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at